Type to search

Bioscience and pharmaceutical Education Insider Only News Technology

NIIMBL receives $83M to tackle vaccine development


NEWARK – The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) was recently awarded $153 million in new funding from its federal partners, including $83 million specifically to work on coronavirus-related projects. “Obviously, there's an element of COVID-19, but also a big part of it is how we make sure we never have this happen

Want to Read More?

Paid DBT subscribers get unlimited access to all Insider content and much more. Learn more in our Insider FAQ.

Become an Insider Now

Already an Insider? Log In.


You Might also Like

Leave a Comment

Your email address will not be published. Required fields are marked *

Get the DBT Book of Lists

The definitive publication of contacts and key information from over 1,500 of Delaware's top businesses and organizations across 60 industries. 

No, thank you.

Free for a limited time! (Normally $50)

Stay updated with our free email newsletter

Keep up with the issues, companies and people that matter most to business in Delaware.

No, thank you.